OL 750 Pill - pink oval, 19mm
Pill with imprint OL 750 is Pink, Oval and has been identified as Levetiracetam 750 mg. It is supplied by Amneal Pharmaceuticals.
Levetiracetam is used in the treatment of Seizures; Epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for OL 750
Levetiracetam
- Imprint
- OL 750
- Strength
- 750 mg
- Color
- Pink
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals
- National Drug Code (NDC)
- 65162-0538 (Discontinued)
- Inactive Ingredients
-
copovidone,
croscarmellose sodium,
magnesium stearate,
polyethylene glycol 3350,
polysorbate 80,
corn starch,
magnesium silicate,
titanium dioxide,
FD&C Red No. 40
Note: Inactive ingredients may vary.
Related images for "OL 750"
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (429)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam (Intravenous) (Advanced Reading)
- Levetiracetam (Oral) (Advanced Reading)
- Levetiracetam Extended-Release Tablets
- Levetiracetam Tablets
Other brands
Keppra, Keppra XR, Elepsia XR, Spritam, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Injection, Concentrate (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Elepsia XR, Spritam, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
